Safety and efficacy of umbilical cord-derived Wharton's jelly compared to hyaluronic acid and saline for knee osteoarthritis: study protocol for a randomized, controlled, single-blind, multi-center trial

Ashim Gupta, Nicola Maffulli, Hugo C Rodriguez, Eric W Carson, Randa A Bascharon, Kristin Delfino, Howard J Levy, Saadiq F El-Amin 3rd, Ashim Gupta, Nicola Maffulli, Hugo C Rodriguez, Eric W Carson, Randa A Bascharon, Kristin Delfino, Howard J Levy, Saadiq F El-Amin 3rd

Abstract

Background: Osteoarthritis (OA) is the most common joint disorder in the United States of America (USA) with a fast-rising prevalence. Current treatment modalities are limited, and total knee replacement surgeries have shown disadvantages, especially for grade II/III OA. The interest in the use of biologics, including umbilical cord (UC)-derived Wharton's jelly (WJ), has grown in recent years. The results from a preliminary study demonstrated the presence of essential components of regenerative medicine, namely growth factors, cytokines, hyaluronic acid (HA), and extracellular vesicles, including exosomes, in WJ. The proposed study aims to evaluate the safety and efficacy of intra-articular injection of UC-derived WJ for the treatment of knee OA symptoms.

Methods: A randomized, controlled, single-blind, multi-center, prospective study will be conducted in which the safety and efficacy of intra-articular administration of UC-derived WJ are compared to HA (control) and saline (placebo control) in patients suffering from grade II/III knee OA. A total of 168 participants with grade II or III knee OA on the KL scale will be recruited across 53 sites in the USA with 56 participants in each arm and followed for 1 year post-injection. Patient satisfaction, Numeric Pain Rating Scale, Knee Injury and Osteoarthritis Outcome Score, 36-Item Short Form Survey (SF-36), and 7-point Likert Scale will be used to assess the participants. Physical exams, X-rays, and MRI with Magnetic Resonance Observation of Cartilage Repair Tissue score will be used to assess improvement in associated anatomy.

Discussion: The study results will provide valuable information into the safety and efficacy of intra-articular administration of Wharton's jelly for grade II/III knee osteoarthritis. The results of this study will also add to the treatment options available for grade II/III OA as well as help facilitate the development of a more focused treatment strategy for patients.

Trial registration: ClinicalTrials.gov, NCT04711304 . Registered on January 15, 2021.

Keywords: Biologics; Exosomes; Extracellular vesicles; Growth factors; Hyaluronic acid; Knee osteoarthritis; Randomized controlled trial; Regenerative medicine; Umbilical cord; Wharton’s jelly.

Conflict of interest statement

AG is a consultant for BioIntegrate. HJL and SFE own equity in BioIntegrate. The remaining authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Summary of the trial design

References

    1. Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res (Hoboken). 2016;68(5):574–580. doi: 10.1002/acr.22721.
    1. Van Manen MD, Nace J, Mont MA. Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners. J Am Osteopath Assoc. 2012;112(11):709–715.
    1. Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am. 2012;94(3):201–207. doi: 10.2106/JBJS.J.01958.
    1. Gupta A, Potty ASR, Ganta D, Mistovich RJ, Penna S, Cady C, Potty AG. Streamlining the KOOS activities of daily living subscale using machine learning. Orthop J Sports Med. 2020;8(3):2325967120910447. doi: 10.1177/2325967120910447.
    1. Farr J, Gomoll AH, Yanke AB, Strauss EJ, Mowry KC, ASA Study Group A randomized controlled single-blind study demonstrating superiority of amniotic suspension allograft injection over hyaluronic acid and saline control for modification of knee osteoarthritis symptoms. J Knee Surg. 2019;32(11):1143–1154. doi: 10.1055/s-0039-1696672.
    1. Hoorntje A, Witjes S, Koenraadt KLM, Aarts R, Weert T, van Greenen RCI. More severe preoperative Kellgren-Lawrence grades of knee osteoarthritis were partially associated with better postoperative patient-reported outcomes in TKA patients. J Knee Surg. 2019;32(3):211–217. doi: 10.1055/s-0038-1635114.
    1. Kahn TL, Soheili A, Schwarzkopf R. Outcomes of total knee arthroplasty in relation to preoperative patient-reported and radiographic measures: data from the osteoarthritis initiative. Geriatr Orthop Surg Rehabil. 2013;4(4):117–126. doi: 10.1177/2151458514520634.
    1. Eyichukwu GO. Non-steroidal anti-inflammatory drugs usage in orthopaedics and trauma practice. A guide and review. Niger J Med. 2010;19(4):374–381. doi: 10.4314/njm.v19i4.61959.
    1. Yasir M, Goyal A, Bansal P, Sonthalia S. Corticosteroids adverse effects. Treasure Island: StatPearl Publishing; 2020-2020 Apr 13. .
    1. Gupta A, Woods MD, Illingworth KD, Niemeier R, Schafer I, Cady C, Filip P, el-Amin SF., III Single walled carbon nanotube composites for bone tissue engineering. J Orthop Res. 2013;31(9):1374–1381. doi: 10.1002/jor.22379.
    1. Gupta A, Main BJ, Taylor BL, Taylor BL, Gupta M, Whitworth CA, et al. In vitro evaluation of three-dimensional single-walled carbon nanotube composites for bone tissue engineering. J Biomed Mater Res A. 2014;102(11):4118–4126. doi: 10.1002/jbm.a.35088.
    1. Gupta A, Liberati TA, Verhulst SJ, Main BJ, Roberts MH, Potty AGR, Pylawka TK, el-Amin III SF. Biocompatibility of single-walled carbon nanotube composites for bone regeneration. Bone Joint Res. 2015;4(5):70–77. doi: 10.1302/2046-3758.45.2000382.
    1. Mohtadi NG, Webster-Bogaert S, Fowler PJ. Limitation of motion following anterior cruciate ligament reconstruction. A case-control study. Am J Sports Med. 1991;19(6):620–624. doi: 10.1177/036354659101900612.
    1. Vallejo R, Gupta A, Kelley CA, Vallejo A, Rink J, Williams JM, Cass CL, Smith WJ, Benyamin R, Cedeño DL. Effects of phase polarity and charge balance spinal cord stimulation on behavior and gene expression in a rat model of neuropathic pain. Neuromodulation. 2020;23(1):26–35. doi: 10.1111/ner.12964.
    1. Gupta A, Sharif K, Walters M, Woods MD, Potty A, Main BJ, et al. Surgical retrieval, isolation and in vitro expansion of human anterior cruciate ligament-derived cells for tissue engineering applications. J Vis Exp. 2014;86:51597.
    1. Gupta A, Kukkar N, Sharif K, Main BJ, Albers CE, El-Amin SF., III Bone graft substitutes for spine fusion: a brief review. Word J Orthop. 2015;6(6):449–456. doi: 10.5312/wjo.v6.i6.449.
    1. Lamplot JD, Rodeo SA, Brophy RH. A practical guide for the current use of biologic therapies in sports medicine. Am J Sports Med. 2020;48(2):488–503. doi: 10.1177/0363546519836090.
    1. Potty AGR, Gupta A, Rodriguez HC, Stone IW, Maffulli N. Intraosseous bioplasty for a subchondral cyst in the lateral condyle of femur. J Clin Med. 2020;9(5):1358. doi: 10.3390/jcm9051358.
    1. Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective. Hum Cell. 2020;33(4):907–918. doi: 10.1007/s13577-020-00407-w.
    1. Rodriguez HC, Gupta M, Cavazos-Escobar E, El-Amin SF, 3rd, Gupta A. Umbilical cord: an allogenic tissue for potential treatment of COVID-19. Hum Cell. 2021;34(1):1–13. doi: 10.1007/s13577-020-00444-5.
    1. Gupta A, Cady C, Fauser AM, Rodriguez HC, Mistovich RJ, Potty AGR, Maffulli N. Cell-free stem cell-derived extract formulation for regenerative medicine applications. Int J Mol Sci. 2020;21(24):9364. doi: 10.3390/ijms21249364.
    1. Main BJ, Valk JA, Maffulli N, Rodriguez HC, Gupta M, Stone IW, el-Amin SF, III, Gupta A. Umbilical cord-derived Wharton’s jelly for regenerative medicine applications in orthopedic surgery: a systematic review protocol. J Orthop Surg Res. 2020;15(1):527. doi: 10.1186/s13018-020-02067-w.
    1. Navani A, Manchikanti L, Albers SL, Latchaw RE, Sanapati J, Kaye AD, Atluri S, Jordan S, Gupta A, Cedeno D, Vallejo A, Fellows B, Knezevic NN, Pappolla M, Diwan S, Trescot AM, Soin A, Kaye AM, Aydin SM, Calodney AK, Candido KD, Bakshi S, Benyamin RM, Vallejo R, Watanabe A, Beall D, Stitik TP, Foye PM, Helander EM, Hirsch JA. Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2019;22(1S):S1–S74.
    1. Gupta A, El-Amin SF, III, Levy HJ, Sze-Tu R, Ibim SE, Maffulli N. Umbilical cord-derived Wharton’s jelly for regenerative medicine applications. J Orthop Surg Res. 2020;15(1):49. doi: 10.1186/s13018-020-1553-7.
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15):e7586. doi: 10.1136/bmj.e7586.
    1. Maffulli N, Rodriguez HC, Stone IW, Nam A, Song A, Gupta M, Alvarado R, Ramon D, Gupta A. Artificial intelligence and machine learning in orthopedic surgery: a systematic review protocol. J Orthop Surg Res. 2020;15(1):478. doi: 10.1186/s13018-020-02002-z.
    1. Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact of estimating prevalence in a US population-based survey. Arthritis Care Res. 2016;68(5):574–580. doi: 10.1002/acr.22721.
    1. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3–25. doi: 10.1016/j.berh.2005.09.007.
    1. Dernek B. Duymus Tm, Koseoglu PK, Aydin T, Kesiktas FN, Aksoy C et al. Efficacy of single-dose hyaluronic acid products with two different structures in patients with early-stage knee osteoarthritis. J Phys Ther Sci. 2016;28(11):3036–3040. doi: 10.1589/jpts.28.3036.
    1. Monovisc® - Summary of safety and efficacy data - . Accessed 23 Mar 2021.
    1. Chevalier X, Sheehan B, Whittington C, Pourrahmat MM, Duarte L, Ngai W, et al. Efficacy and safety of Hylan G-F 20 versus intra-articular corticosteroids in people with knee osteoarthritis: a systematic review and network meta-analysis. Clin Med Insights Arthritis Musculoskelet. 2020;13:1179544120967370.
    1. Bowman S, Awad ME, Hamrick MW, Hunter M, Fulzele S. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Transl Med. 2018;7(1):6. doi: 10.1186/s40169-017-0180-3.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj